Correlation Between Serum Uric Acid and Pulmonary Hypertension in Obstructive Sleep Apnea Syndrome
NCT ID: NCT05967754
Last Updated: 2023-08-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2018-01-01
2020-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Echocardiographic Assessment of Pulmonary Hypertension in Obstructive Sleep Apnea
NCT07184060
Assessment of Pulmonary Artery Pressure and Right Sided Hemodynamics in Patients With OSA Before and After CPAP TTT
NCT03276611
New Perspective on Exploring the Post-apneic BP Surge in Patients With OSA
NCT06172998
Vascular Pathophysiology in Obstructive Sleep Apnea
NCT00214084
Cardiorespiratory Responses to Exercise in Elderly
NCT03307928
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
AIM OF THE WORK This study aimed to correlate serum uric acid levels and PAH in OSAHS patients. Methods We enrolled 100 patients diagnosed with OSAHS using polysomnography. Patients were divided into three severity groups: mild OSA (5 ≤ AHI \< 15), moderate OSA (15 ≤ AHI \< 30), and severe (30 ≤ AHI \< 60). Serum uric acid was measured the morning after polysomnography. All patients underwent standard echocardiograms, and Pulmonary artery systolic pressure calculation was done.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with Obstructive sleep Apnea
Patients with Obstructive sleep Apnea
polysomnography
polysomnography and serum uric acid measurement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
polysomnography
polysomnography and serum uric acid measurement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ≥18 years old.
Exclusion Criteria
* Hemodynamically unstable patients
* Patients with other chronic respiratory or cardiac diseases
* Patients with other known causes of pulmonary hypertension
* Patients with any disease or on medication that could alter excretion or urinary metabolism of uric acid such as Excessive uric acid production
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alexandria University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rania Ahmad Sweed
clinical professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
rania A SEWIED, doctor
Role: PRINCIPAL_INVESTIGATOR
alex
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rania Ahmad Sweed
Alexandria, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24/327
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.